PeterLabs Holdings Berhad (KLSE:PLABS)
0.2250
-0.0050 (-2.17%)
At close: Nov 20, 2026
PeterLabs Holdings Berhad Revenue
In the fiscal year ending June 30, 2026, PeterLabs Holdings Berhad had annual revenue of 63.47M MYR with 8.13% growth. PeterLabs Holdings Berhad had revenue of 17.00M in the quarter ending June 30, 2026. That makes PeterLabs Holdings Berhad the 35,330th largest company in the world by revenue and 840th in Malaysia.
Revenue
63.47M
Revenue Growth
+8.13%
P/S Ratio
0.98
Revenue / Employee
n/a
Employees
n/a
Market Cap
61.92M
Revenue by Segment
Fiscal year ended Jun 30, 2026 See the full PeterLabs Holdings Berhad breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 63.47M | 4.77M | 8.13% |
| Jun 30, 2025 | 58.70M | -117.34M | -66.66% |
| Dec 31, 2024 | 176.03M | -10.18M | -5.47% |
| Dec 31, 2023 | 186.21M | 24.58M | 15.20% |
| Dec 31, 2022 | 161.63M | -22.19M | -12.07% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DXN Holdings Bhd. | 1.92B |
| Duopharma Biotech Berhad | 916.98M |
| Y.S.P. Southeast Asia Holding Berhad | 370.79M |
| Kotra Industries Berhad | 233.17M |
| Rhone Ma Holdings Berhad | 228.88M |
| Sunzen Group Berhad | 93.59M |
| Nova Wellness Group Berhad | 49.74M |
| Bioalpha Holdings Berhad | 10.93M |